Rivastigmine 3M Health Care Ltd 欧盟 - 斯洛文尼亚文 - EMA (European Medicines Agency)

rivastigmine 3m health care ltd

3m health care limited - rivastigmin - alzheimerjeva bolezen - psychoanaleptics, , anticholinesterases - simptomatsko zdravljenje blage do zmerno hude alzheimerjeve demence.

Vosevi 欧盟 - 斯洛文尼亚文 - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitis c, kronični - antivirusi za sistemsko uporabo - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (glej točki 4. 2, 4. 4 in 5.

Givlaari 欧盟 - 斯洛文尼亚文 - EMA (European Medicines Agency)

givlaari

alnylam netherlands b.v. - givosiran - porphyrias, jeter - različne zdravljene bolezni prebavil in presnove izdelki - zdravljenje akutna okvara porphyria (ahp) pri odraslih in mladostnikih, starih 12 let in več.

Plerixafor Accord 欧盟 - 斯洛文尼亚文 - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

Aldemyl 4,6 mg/24 ur transdermalni obliž 斯洛文尼亚 - 斯洛文尼亚文 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aldemyl 4,6 mg/24 ur transdermalni obliž

generics (uk) ltd. - rivastigmin - transdermalni obliž - rivastigmin 9 mg / 1 obliž - rivastigmin

Emerpand 13,3 mg/24 h transdermalni obliž 斯洛文尼亚 - 斯洛文尼亚文 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

emerpand 13,3 mg/24 h transdermalni obliž

actavis group ptc ehf. - rivastigmin - transdermalni obliž - rivastigmin 27 mg / 1 obliž - rivastigmin

Emerpand 9,5 mg/24 h transdermalni obliž 斯洛文尼亚 - 斯洛文尼亚文 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

emerpand 9,5 mg/24 h transdermalni obliž

actavis group ptc ehf. - rivastigmin - transdermalni obliž - rivastigmin 18 mg / 1 obliž - rivastigmin